- Behind Generate’s ‘feverish’ race to raise $400M IPO while window remains open Fierce Biotech
- Generate Biomedicines shares fall in weak Nasdaq debut for drug developer Reuters
- Generate caps a strong month for biotech IPOs with $400M offering BioPharma Dive
- Flagship-Backed Generate Biomedicines Raises $400 Million in IPO Yahoo Finance
- Generate:Biomedicines Rings the Opening Bell Nasdaq